UNSPSC 51451609: Etibendazole

This classification denotes an antihelminthic agent with the molecular formula C18H16FN3O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 1XU086MM3H, chemically known as r 34,803 but generally known as etibendazole, which bears US NIH Compound Identifier 71745. European Medicines Agency schedules Etibendazole in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07295MIG.

UNSPSC 51451609 Etibendazole, a Commodity code, shows minimal recent state and local procurement activity aligned with its nominal scope. The code is intended to capture purchases of etibendazole, an anthelmintic pharmaceutical product, but recent opportunities tagged under it do not reflect procurement of that drug. Instead, the Illinois Department of Public Health's piggyback pharmaceutical warehouse award through MMCAP Infuse (posted August 28, 2026; awarded to Chartwell Rx LLC for $2,999,999.11 over three years with renewals) supplied Doxycycline Hyclate and Ciprofloxacin Hydrochloride—antibiotics unrelated to the code's stated commodity. Seminole County, Florida's Naloxone and Safe Drug Deactivation Systems IFB (posted June 30, 2026; response deadline July 26, 2026) procured emergency-response pharmaceuticals and equipment, again misaligned with etibendazole's anthelmintic classification. Neither opportunity represents actual sourcing of etibendazole.

The recent-opportunity block reveals a mismatch between the code's definition and what state and local buyers are requesting under it. Illinois Department of Public Health and Seminole County are the only issuing bodies with recent records, and their procurements target different drug classes and delivery models—one a piggyback cooperative award for warehouse antibiotics, the other a competitive IFB for emergency-response supplies. Geographic activity is limited to Illinois and Florida. The code does not currently signal active market demand for etibendazole itself; procurement professionals should verify whether state and local health departments actually source this agent separately, or whether it is bundled under broader pharmaceutical frameworks that use different UNSPSC tags.